Key result
Current methods for monitoring antiplatelet medication, such as the PFA-100 and standard TEG, lack specificity or sensitivity, highlighting the need for more robust platelet function assessments.
No takes yet. Share an insight, caveat, or question.
Highlights the limitations of current platelet function monitoring devices (PFA-100, TEG) for assessing the effects of antiplatelet medication in the perioperative setting.
R. Self (2003) conducted a letter in Antiplatelet medication monitoring. Platelet function assessment (PFA-100, TEG) was evaluated. Current methods for monitoring antiplatelet medication, such as the PFA-100 and standard TEG, lack specificity or sensitivity, highlighting the need for more robust platelet function assessments.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: